Janine Copp (@jn_copp) 's Twitter Profile
Janine Copp

@jn_copp

antibodies | enzymes | protein engineering | sciencemom | Kiwi | Canadian

ID: 154446879

calendar_today11-06-2010 07:29:11

200 Tweet

155 Followers

311 Following

Center for the Multiplex Assessment of Phenotype (@cegs_cmap) 's Twitter Profile Photo

We have an incredible speaker lineup for Day 1 of the Mutational Scanning Symposium! Which includes talks from Martin Kampmann Prashant Mali @JohnDoench Broad Institute #genomics #proteomics #transcriptome #VUS #varianteffect21 #future Learn more & register bit.ly/3tFmybH

Matt Krisiloff (@mattkrisiloff) 's Twitter Profile Photo

'Science Startups - Who's Hiring?' A lot of scientists have a hard time finding cool startup opportunities. Trying an experiment to help. Science startups -- reply with 1 tweet on your mission, roles looking for, and how to learn more. Everyone -- RT so more scientists see!

Charlotte Miton (@charlottemiton) 's Twitter Profile Photo

Our latest review on Epistasis in Protein Evolution is out in Current Opinion in Structural Biology! Congrats Karol Buda on your first paper and thank you Amir Aharoni and Bryan Dickinson bryan dickinson for the kind invitation. Tokuriki lab Current Opinion/Research in Structural Biology sciencedirect.com/science/articl…

Our latest review on Epistasis in Protein Evolution is out in Current Opinion in Structural Biology! Congrats Karol Buda on your first paper and thank you Amir Aharoni and Bryan Dickinson <a href="/chembioBryan/">bryan dickinson</a> for the kind invitation. <a href="/tokuriki_lab/">Tokuriki lab</a>   <a href="/COSB_CRSB/">Current Opinion/Research in Structural Biology</a> sciencedirect.com/science/articl…
Fred Hutchinson Cancer Center (@fredhutch) 's Twitter Profile Photo

.Tyler Starr from the Bloom Lab set out to shed light on a problem facing antibody treatments for #COVID19. Some variants of #SARSCoV2 have acquired mutations that enable the virus to escape the antibodies’ grasp. Read more from Nature Portfolio: go.nature.com/3z0Q4uX

.<a href="/tylernstarr/">Tyler Starr</a> from the <a href="/jbloom_lab/">Bloom Lab</a> set out to shed light on a problem facing antibody treatments for #COVID19. Some variants of #SARSCoV2 have acquired mutations that enable the virus to escape the antibodies’ grasp. Read more from <a href="/NaturePortfolio/">Nature Portfolio</a>: go.nature.com/3z0Q4uX
Tokuriki lab (@tokuriki_lab) 's Twitter Profile Photo

We have open positions for posdocs/graduate students in our lab University of British Columbia Michael Smith Labs with a focus on the evolution of antibiotic resistance using protein bioinformatics, experimental evolution and/or deep mutational scanning. Please share! tokurikilab.msl.ubc.ca

Grant (@synbiogrant) 's Twitter Profile Photo

Excited to share that we are hiring for a new Senior Scientist Merck #ProteinEngineering. Come join the bioengineering revolution as we invent novel enzymes and therapeutic proteins. #ProteinDesign #SynBio #MerckChemistry msd.wd5.myworkdayjobs.com/SearchJobs/job…

Ania Fryszkowska (@fryania) 's Twitter Profile Photo

Want to develop #biocatalytic routes to new therapeutics with us? #MerckChemistry and #Biocatalysis group are looking for innovators, creative thinkers, rock-star chemists and protein engineers to help us imagine the future of drug manufacture. jobs.merck.com/us/en/job/R976…

eLife - the journal (@elife) 's Twitter Profile Photo

The longest-running evolution experiment in yeast confirms findings from the famous long-term evolution experiment in E. coli and identifies interesting differences. Retweet if your network should learn about this window into evolution elifesciences.org/articles/63910…

The longest-running evolution experiment in yeast confirms findings from the famous long-term evolution experiment in E. coli and identifies interesting differences. Retweet if your network should learn about this window into evolution elifesciences.org/articles/63910…
PlesaLab (@plesalab) 's Twitter Profile Photo

We have two PhD openings in our lab. One on developing multiplexed protein-protein interaction assays and another on the use of ML for predicting seq-function relationships. Application deadline for our BioEng PhD program is Dec 15: bioengineering.uoregon.edu/academics

Mark Budde (hiring wetlab, DMs open) 🦕🏆 (@markwbudde) 's Twitter Profile Photo

Primordium is now offering everyone the chance to sample our full-plasmid sequencing service for FREE - never use Sanger sequencing again! Please retweet this message and we'll DM you a coupon to sequence 5 ENTIRE PLASMIDS 100% FREE, no CC or PO needed. primordiumlabs.com 5/

Primordium is now offering everyone the chance to sample our full-plasmid sequencing service for FREE - never use Sanger sequencing again! Please retweet this message and we'll DM you a coupon to sequence 5 ENTIRE PLASMIDS 100% FREE, no CC or PO needed. primordiumlabs.com 5/
Grant (@synbiogrant) 's Twitter Profile Photo

Merck #ProteinEngineering is hiring! Are you passionate about inventing new protein functions? Join our bioengineering revolution! #SynBio #ProteinDesign #DirectedEvolution #MolBio #Microfluidics jobs.merck.com/us/en/job/R170…

AbCellera (@abcellerabio) 's Twitter Profile Photo

Combine a diverse, developable, and validated panel of CD3-binding antibodies with a clinically-validated #bispecific engineering platform to develop new T cell engagers for cancer. See the data at #AACR22. bit.ly/3uaugNZ

Combine a diverse, developable, and validated panel of CD3-binding antibodies with a clinically-validated #bispecific engineering platform to develop new T cell engagers for cancer. See the data at #AACR22.
bit.ly/3uaugNZ
Machine learning for protein engineering seminar (@ml4proteins) 's Twitter Profile Photo

Excited to announce our next set of speakers! June 7th — Brian Hie: on using language models to evolve antibodies June 21st — Danny Diaz on engineering a more efficient PETase June 7th — gabefoley on ancestral reconstruction with GRASP ml4proteinengineering.com/signup

AbCellera (@abcellerabio) 's Twitter Profile Photo

There has been a chronic underinvestment in tech that accelerates drug discovery and reduces risk. So, we asked ourselves: can it be built better? Join us at #BIO2022 to learn how AbCellera is creating a better front end to antibody drug development. ow.ly/FZWQ50JsQgf

There has been a chronic underinvestment in tech that accelerates drug discovery and reduces risk. So, we asked ourselves: can it be built better?

Join us at #BIO2022 to learn how AbCellera is creating a better front end to antibody drug development.

ow.ly/FZWQ50JsQgf